Development and Mechanism of γ-secretase Modulators for Alzheimer's Disease

Overview

Journal Biochemistry

Specialty Biochemistry

Date 2013 Apr 26

PMID 23614767

Citations 71

Authors

Christina J Crump

Douglas S Johnson

Yue-Ming Li

Affiliations

Soon will be listed here.

Abstract

γ-Secretase is an aspartyl intramembranal protease composed of presenilin, Nicastrin, Aph1, and Pen2 with 19 transmembrane domains. γ-Secretase cleaves the amyloid precursor proteins (APP) to release Aβ peptides that likely play a causative role in the pathogenesis of Alzheimer's disease (AD). In addition, γ-secretase cleaves Notch and other type I membrane proteins. γ-Secretase inhibitors (GSIs) have been developed and used for clinical studies. However, clinical trials have shown adverse effects of GSIs that are potentially linked with nondiscriminatory inhibition of Notch signaling, overall APP processing, and other substrate cleavages. Therefore, these findings call for the development of disease-modifying agents that target γ-secretase activity to lower levels of Aβ42 production without blocking the overall processing of γ-secretase substrates. γ-Secretase modulators (GSMs) originally derived from nonsteroidal anti-inflammatory drugs (NSAIDs) display such characteristics and are the focus of this review. However, first-generation GSMs have limited potential because of the low potency and undesired neuropharmacokinetic properties. This generation of GSMs has been suggested to interact with the APP substrate, γ-secretase, or both. To improve the potency and brain availability, second-generation GSMs, including NSAID-derived carboxylic acid and non-NSAID-derived heterocyclic chemotypes, as well as natural product-derived GSMs have been developed. Animal studies of this generation of GSMs have shown encouraging preclinical profiles. Moreover, using potent GSM photoaffinity probes, multiple studies unambiguously have showed that both carboxylic acid and heterocyclic GSMs specifically target presenilin, the catalytic subunit of γ-secretase. In addition, two types of GSMs have distinct binding sites within the γ-secretase complex and exhibit different Aβ profiles. GSMs induce a conformational change of γ-secretase to achieve modulation. Various models are proposed and discussed. Despite the progress of GSM research, many outstanding issues remain to be investigated to achieve the ultimate goal of developing GSMs as effective AD therapies.

Citing Articles

Review on anti-alzheimer drug development: approaches, challenges and perspectives.

Abdallah A RSC Adv. 2024; 14(16):11057-11088.

PMID: 38586442 PMC: 10995770. DOI: 10.1039/d3ra08333k.

Unraveling the therapeutic efficacy of resveratrol in Alzheimer's disease: an umbrella review of systematic evidence.

Azargoonjahromi A, Abutalebian F Nutr Metab (Lond). 2024; 21(1):15.

PMID: 38504306 PMC: 10953289. DOI: 10.1186/s12986-024-00792-1.

Microbial infection promotes amyloid pathology in a mouse model of Alzheimer's disease via modulating γ-secretase.

Zhao M, Ma G, Yan X, Li X, Wang E, Xu X Mol Psychiatry. 2024; 29(5):1491-1500.

PMID: 38273109 DOI: 10.1038/s41380-024-02428-5.

The efficacy and safety of anti-Aβ agents for delaying cognitive decline in Alzheimer's disease: a meta-analysis.

Li J, Wu X, Tan X, Wang S, Qu R, Wu X Front Aging Neurosci. 2023; 15:1257973.

PMID: 38020763 PMC: 10661413. DOI: 10.3389/fnagi.2023.1257973.

Structure-activity relationship of BMS906024 derivatives for Cryptosporidium parvum growth inhibition.

Lee S, Love M, Modukuri R, Chatterjee A, Huerta L, Lawson A Bioorg Med Chem Lett. 2023; 90:129328.

PMID: 37196868 PMC: 10290938. DOI: 10.1016/j.bmcl.2023.129328.

References

Skovronsky D, Moore D, Milla M, Doms R, Lee V . Protein kinase C-dependent alpha-secretase competes with beta-secretase for cleavage of amyloid-beta precursor protein in the trans-golgi network. J Biol Chem. 2000; 275(4):2568-75. DOI: 10.1074/jbc.275.4.2568. View

Wang R, Tang P, Wang P, Boissy R, Zheng H . Regulation of tyrosinase trafficking and processing by presenilins: partial loss of function by familial Alzheimer's disease mutation. Proc Natl Acad Sci U S A. 2005; 103(2):353-8. PMC: 1326180. DOI: 10.1073/pnas.0509822102. View

Hall A, Elliott R, Giblin G, Hussain I, Musgrave J, Naylor A . Piperidine-derived gamma-secretase modulators. Bioorg Med Chem Lett. 2010; 20(3):1306-11. DOI: 10.1016/j.bmcl.2009.08.072. View

Lobry C, Oh P, Aifantis I . Oncogenic and tumor suppressor functions of Notch in cancer: it's NOTCH what you think. J Exp Med. 2011; 208(10):1931-5. PMC: 3182047. DOI: 10.1084/jem.20111855. View

Portelius E, Van Broeck B, Andreasson U, Gustavsson M, Mercken M, Zetterberg H . Acute effect on the Aβ isoform pattern in CSF in response to γ-secretase modulator and inhibitor treatment in dogs. J Alzheimers Dis. 2010; 21(3):1005-12. DOI: 10.3233/JAD-2010-100573. View

Pettersson M, Kauffman G, Am Ende C, Patel N, Stiff C, Tran T . Novel γ-secretase modulators: a review of patents from 2008 to 2010. Expert Opin Ther Pat. 2011; 21(2):205-26. DOI: 10.1517/13543776.2011.547479. View

Qi-Takahara Y, Morishima-Kawashima M, Tanimura Y, Dolios G, Hirotani N, Horikoshi Y . Longer forms of amyloid beta protein: implications for the mechanism of intramembrane cleavage by gamma-secretase. J Neurosci. 2005; 25(2):436-45. PMC: 6725472. DOI: 10.1523/JNEUROSCI.1575-04.2005. View

Kounnas M, Danks A, Cheng S, Tyree C, Ackerman E, Zhang X . Modulation of gamma-secretase reduces beta-amyloid deposition in a transgenic mouse model of Alzheimer's disease. Neuron. 2010; 67(5):769-80. PMC: 2947312. DOI: 10.1016/j.neuron.2010.08.018. View

Weggen S, ERIKSEN J, Das P, Sagi S, Wang R, Pietrzik C . A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature. 2001; 414(6860):212-6. DOI: 10.1038/35102591. View

10.

Findeis M, Schroeder F, McKee T, Yager D, Fraering P, Creaser S . Discovery of a novel pharmacological and structural class of gamma secretase modulators derived from the extract of Actaea racemosa. ACS Chem Neurosci. 2012; 3(11):941-51. PMC: 3509716. DOI: 10.1021/cn3000857. View

11.

Lleo A, Berezovska O, Herl L, Raju S, Deng A, Bacskai B . Nonsteroidal anti-inflammatory drugs lower Abeta42 and change presenilin 1 conformation. Nat Med. 2004; 10(10):1065-6. DOI: 10.1038/nm1112. View

12.

Capell A, Beher D, Prokop S, Steiner H, Kaether C, Shearman M . Gamma-secretase complex assembly within the early secretory pathway. J Biol Chem. 2004; 280(8):6471-8. DOI: 10.1074/jbc.M409106200. View

13.

Goate A, Chartier-Harlin M, Mullan M, Brown J, Crawford F, Fidani L . Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991; 349(6311):704-6. DOI: 10.1038/349704a0. View

14.

Jumpertz T, Rennhack A, Ness J, Baches S, Pietrzik C, Bulic B . Presenilin is the molecular target of acidic γ-secretase modulators in living cells. PLoS One. 2012; 7(1):e30484. PMC: 3253113. DOI: 10.1371/journal.pone.0030484. View

15.

Li Y, Lai M, Xu M, Huang Q, Sardana M, Shi X . Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state. Proc Natl Acad Sci U S A. 2000; 97(11):6138-43. PMC: 18571. DOI: 10.1073/pnas.110126897. View

16.

Mitani Y, Yarimizu J, Saita K, Uchino H, Akashiba H, Shitaka Y . Differential effects between γ-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice. J Neurosci. 2012; 32(6):2037-50. PMC: 6621706. DOI: 10.1523/JNEUROSCI.4264-11.2012. View

17.

Okochi M, Tagami S, Yanagida K, Takami M, Kodama T, Mori K . γ-secretase modulators and presenilin 1 mutants act differently on presenilin/γ-secretase function to cleave Aβ42 and Aβ43. Cell Rep. 2013; 3(1):42-51. DOI: 10.1016/j.celrep.2012.11.028. View

18.

Green R, Schneider L, Amato D, Beelen A, Wilcock G, Swabb E . Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial. JAMA. 2009; 302(23):2557-64. PMC: 2902875. DOI: 10.1001/jama.2009.1866. View

19.

Edbauer D, Winkler E, Regula J, Pesold B, Steiner H, Haass C . Reconstitution of gamma-secretase activity. Nat Cell Biol. 2003; 5(5):486-8. DOI: 10.1038/ncb960. View

20.

Lai M, Chen E, Crouthamel M, DiMuzio-Mower J, Xu M, Huang Q . Presenilin-1 and presenilin-2 exhibit distinct yet overlapping gamma-secretase activities. J Biol Chem. 2003; 278(25):22475-81. DOI: 10.1074/jbc.M300974200. View